Related Articles
RESULTS OF A CLINICAL MULTICENTRIC RANDOMIZED PHASE-II STUDY OF NONSMALL CELL LUNG-CANCER TREATED WITH VINORELBINE CISPLATIN VERSUS VINORELBINE ALONE
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy
A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: A phase II trial
Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer